期刊文献+

人淋巴瘤细胞Jurkat通过Fas/FasL途径抑制人肺癌细胞A549的免疫逃逸 被引量:7

Immune Evasion of Human Lung Carcinoma Cell A549 Suppressed by Human Lymphoma Cell Jurkat via Fas/FasL Pathway
暂未订购
导出
摘要 背景与目的当机体发生肿瘤时,肿瘤细胞可以多种方式逃避免疫系统的监控而分裂生长,这就是肿瘤的免疫逃逸。研究表明,肿瘤细胞自身凋亡减少以及机体免疫细胞凋亡增加是肿瘤免疫逃逸的重要机制。Fas/FasL系统是介导凋亡的重要分子体系,本研究旨在通过观察人淋巴瘤细胞株Jurkat诱导人肺癌细胞株A549凋亡过程中凋亡信号分子Fas、FasL及Caspase-8表达的改变,从而探讨Fas/FasL途径在肺癌细胞免疫逃逸中的作用。方法人肺癌细胞株A549与人淋巴瘤细胞株Jurkat以不同比例分别进行共同培养,采用台盼蓝拒染法检测两种细胞存活率;流式细胞术(flowcytometry,FCM)检测两种细胞的凋亡率;Westernblot技术检测A549细胞中Fas、FasL及Caspase-8蛋白表达水平。结果随着Jurkat/A549细胞比例逐渐增大,A549细胞的凋亡率明显增加,Jurkat细胞凋亡率显著减少;同时A549细胞中Fas及Caspase-8蛋白的表达水平明显上调,而对FasL蛋白的表达水平无明显影响。结论Jurkat细胞可能通过Fas/FasL途径介导了人肺癌细胞株A549的凋亡,从而抑制了A549细胞的免疫逃逸。 Background and objective Tumor escape from the host immune system has been a major problem in immunotherapy of human malignancies. FasL/Fas-induced apoptosis plays an important role in various immunological processes. The aim of this study is to investigate the immune evasion in human lung carcinoma cell A549 induced by human lymphoma cell Jurkat via Fas/FasL pathway. Methods Jurkat cells and A549 cells were co-cultured at different proportions. The apoptotic rates of A549 cells were determined by flow cytometry (FCM). Protein levels of Fas, FasL and Caspase-8 in A549 cells were detected by Western blot. Results Survival rates of A549 cells gradually decreased and apoptotic rates of A549 cells were significantly enhanced along with ratio increasing between Jurkat and A549. Meanwhile, the protein levels of Fas and Caspase-8 gradually increased in A549 cells, and the protein levels of FasL had no significant difference in all groups. Conclusion The Jurkat cells might decrease the survival rates of A549 cells and enhanced its apoptosis and immune evasion partly via Fas/FasL pathway.
出处 《中国肺癌杂志》 CAS 2010年第7期681-685,共5页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 凋亡 免疫逃逸 Lung neoplasms Apoptosis Immune evasion
  • 相关文献

参考文献13

  • 1Whiteside TL. Tricks tumors Use to escape from immune control. Oral Oncol, 2009, 45(10): 119-123.
  • 2Lu B, Finn OJ. T-cell death and cancer immune tolerance. CeU Death Differ, 2008, 15(1): 70-79.
  • 3Kassalm D, Nachbur U, Conus S, et al. Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells. Cell Death Differ, 2009, 16(1): 115-124.
  • 4向青,徐波,徐梅.Fas/FasL途径介导的人肺癌细胞免疫逃逸[J].中国病理生理杂志,2006,22(1):168-171. 被引量:15
  • 5韩阳,官大威,侯震寰,赵锐,路斌.caspase-8及其研究进展[J].中国法医学杂志,2006,21(2):94-96. 被引量:9
  • 6Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science,1995, 270(5239): 1189-1192.
  • 7Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion. Nat Med. 1996. 2(12): 1361-1366.
  • 8许欣,彭林涛,刘丽华,王佩,左连富.食管上皮癌变过程中FAS、FASL、FADD和caspase-8的表达及其意义[J].基础医学与临床,2007,27(5):525-529. 被引量:6
  • 9Christian L, Daniela L, Nadine S. Molecular mechanism of mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-a signaling. Apoptosis, 2007, 12(12): 2259-2270.
  • 10Zang F, Sun B, Zhao X, et al. Critical role for c-FLIPL on Fas resistance in colon carcinoma cell line HT-29. Cell Biol Int, 2008, 32(3): 329-336.

二级参考文献61

共引文献63

同被引文献116

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部